[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Rabies Immune Globulin (Human) Supply, Demand and Key Producers, 2023-2029

July 2024 | 121 pages | ID: G4BAF0952F92EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Rabies Immune Globulin (Human) market size is expected to reach $ 2007.6 million by 2029, rising at a market growth of 3.8% CAGR during the forecast period (2023-2029).

The market for Rabies Immune Globulin (Human) is primarily driven by the incidence of rabies in different regions of the world. According to the World Health Organization, rabies is present in more than 150 countries, with an estimated 59,000 human deaths annually. The majority of these deaths occur in Asia and Africa, where access to post-exposure prophylaxis may be limited.

In addition, the market for Rabies Immune Globulin (Human) is also influenced by government policies and regulations related to rabies prevention and control. Many countries have established national vaccination programs and guidelines for post-exposure prophylaxis, which may include the use of Rabies Immune Globulin (Human).

Overall, the market for Rabies Immune Globulin (Human) is expected to continue to grow as awareness of rabies and the importance of post-exposure prophylaxis increases, particularly in regions with high incidence of the disease.

This report studies the global Rabies Immune Globulin (Human) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rabies Immune Globulin (Human), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rabies Immune Globulin (Human) that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Rabies Immune Globulin (Human) total production and demand, 2018-2029, (K Units)

Global Rabies Immune Globulin (Human) total production value, 2018-2029, (USD Million)

Global Rabies Immune Globulin (Human) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rabies Immune Globulin (Human) consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Rabies Immune Globulin (Human) domestic production, consumption, key domestic manufacturers and share

Global Rabies Immune Globulin (Human) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Rabies Immune Globulin (Human) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rabies Immune Globulin (Human) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Rabies Immune Globulin (Human) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Sanofi, Kamada, Bharat Serum, Bio Products Laboratory, Shanghai RAAS, Weiguang Bio and Shuanglin Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rabies Immune Globulin (Human) market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rabies Immune Globulin (Human) Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Rabies Immune Globulin (Human) Market, Segmentation by Type
  • HyperRAB S/D
  • KEDRAB
Global Rabies Immune Globulin (Human) Market, Segmentation by Application
  • Clinic
  • Hospital
Companies Profiled:
  • CSL Behring
  • Grifols
  • Sanofi
  • Kamada
  • Bharat Serum
  • Bio Products Laboratory
  • Shanghai RAAS
  • Weiguang Bio
  • Shuanglin Bio
  • CBPO
  • CNBG
  • Sichuan Yuanda Shuyang
  • Kedrion Biopharma
  • Congruent Pharmachem
  • hualanbio
Key Questions Answered

1. How big is the global Rabies Immune Globulin (Human) market?

2. What is the demand of the global Rabies Immune Globulin (Human) market?

3. What is the year over year growth of the global Rabies Immune Globulin (Human) market?

4. What is the production and production value of the global Rabies Immune Globulin (Human) market?

5. Who are the key producers in the global Rabies Immune Globulin (Human) market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Rabies Immune Globulin (Human) Introduction
1.2 World Rabies Immune Globulin (Human) Supply & Forecast
  1.2.1 World Rabies Immune Globulin (Human) Production Value (2018 & 2022 & 2029)
  1.2.2 World Rabies Immune Globulin (Human) Production (2018-2029)
  1.2.3 World Rabies Immune Globulin (Human) Pricing Trends (2018-2029)
1.3 World Rabies Immune Globulin (Human) Production by Region (Based on Production Site)
  1.3.1 World Rabies Immune Globulin (Human) Production Value by Region (2018-2029)
  1.3.2 World Rabies Immune Globulin (Human) Production by Region (2018-2029)
  1.3.3 World Rabies Immune Globulin (Human) Average Price by Region (2018-2029)
  1.3.4 North America Rabies Immune Globulin (Human) Production (2018-2029)
  1.3.5 Europe Rabies Immune Globulin (Human) Production (2018-2029)
  1.3.6 China Rabies Immune Globulin (Human) Production (2018-2029)
  1.3.7 Japan Rabies Immune Globulin (Human) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Rabies Immune Globulin (Human) Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Rabies Immune Globulin (Human) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Rabies Immune Globulin (Human) Demand (2018-2029)
2.2 World Rabies Immune Globulin (Human) Consumption by Region
  2.2.1 World Rabies Immune Globulin (Human) Consumption by Region (2018-2023)
  2.2.2 World Rabies Immune Globulin (Human) Consumption Forecast by Region (2024-2029)
2.3 United States Rabies Immune Globulin (Human) Consumption (2018-2029)
2.4 China Rabies Immune Globulin (Human) Consumption (2018-2029)
2.5 Europe Rabies Immune Globulin (Human) Consumption (2018-2029)
2.6 Japan Rabies Immune Globulin (Human) Consumption (2018-2029)
2.7 South Korea Rabies Immune Globulin (Human) Consumption (2018-2029)
2.8 ASEAN Rabies Immune Globulin (Human) Consumption (2018-2029)
2.9 India Rabies Immune Globulin (Human) Consumption (2018-2029)

3 WORLD RABIES IMMUNE GLOBULIN (HUMAN) MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Rabies Immune Globulin (Human) Production Value by Manufacturer (2018-2023)
3.2 World Rabies Immune Globulin (Human) Production by Manufacturer (2018-2023)
3.3 World Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023)
3.4 Rabies Immune Globulin (Human) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Rabies Immune Globulin (Human) Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Rabies Immune Globulin (Human) in 2022
  3.5.3 Global Concentration Ratios (CR8) for Rabies Immune Globulin (Human) in 2022
3.6 Rabies Immune Globulin (Human) Market: Overall Company Footprint Analysis
  3.6.1 Rabies Immune Globulin (Human) Market: Region Footprint
  3.6.2 Rabies Immune Globulin (Human) Market: Company Product Type Footprint
  3.6.3 Rabies Immune Globulin (Human) Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Rabies Immune Globulin (Human) Production Value Comparison
  4.1.1 United States VS China: Rabies Immune Globulin (Human) Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Rabies Immune Globulin (Human) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Rabies Immune Globulin (Human) Production Comparison
  4.2.1 United States VS China: Rabies Immune Globulin (Human) Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Rabies Immune Globulin (Human) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Rabies Immune Globulin (Human) Consumption Comparison
  4.3.1 United States VS China: Rabies Immune Globulin (Human) Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Rabies Immune Globulin (Human) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Rabies Immune Globulin (Human) Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Rabies Immune Globulin (Human) Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023)
4.5 China Based Rabies Immune Globulin (Human) Manufacturers and Market Share
  4.5.1 China Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Rabies Immune Globulin (Human) Production Value (2018-2023)
  4.5.3 China Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023)
4.6 Rest of World Based Rabies Immune Globulin (Human) Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Rabies Immune Globulin (Human) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 HyperRAB S/D
  5.2.2 KEDRAB
5.3 Market Segment by Type
  5.3.1 World Rabies Immune Globulin (Human) Production by Type (2018-2029)
  5.3.2 World Rabies Immune Globulin (Human) Production Value by Type (2018-2029)
  5.3.3 World Rabies Immune Globulin (Human) Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Rabies Immune Globulin (Human) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Clinic
  6.2.2 Hospital
6.3 Market Segment by Application
  6.3.1 World Rabies Immune Globulin (Human) Production by Application (2018-2029)
  6.3.2 World Rabies Immune Globulin (Human) Production Value by Application (2018-2029)
  6.3.3 World Rabies Immune Globulin (Human) Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 CSL Behring
  7.1.1 CSL Behring Details
  7.1.2 CSL Behring Major Business
  7.1.3 CSL Behring Rabies Immune Globulin (Human) Product and Services
  7.1.4 CSL Behring Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 CSL Behring Recent Developments/Updates
  7.1.6 CSL Behring Competitive Strengths & Weaknesses
7.2 Grifols
  7.2.1 Grifols Details
  7.2.2 Grifols Major Business
  7.2.3 Grifols Rabies Immune Globulin (Human) Product and Services
  7.2.4 Grifols Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Grifols Recent Developments/Updates
  7.2.6 Grifols Competitive Strengths & Weaknesses
7.3 Sanofi
  7.3.1 Sanofi Details
  7.3.2 Sanofi Major Business
  7.3.3 Sanofi Rabies Immune Globulin (Human) Product and Services
  7.3.4 Sanofi Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Sanofi Recent Developments/Updates
  7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Kamada
  7.4.1 Kamada Details
  7.4.2 Kamada Major Business
  7.4.3 Kamada Rabies Immune Globulin (Human) Product and Services
  7.4.4 Kamada Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Kamada Recent Developments/Updates
  7.4.6 Kamada Competitive Strengths & Weaknesses
7.5 Bharat Serum
  7.5.1 Bharat Serum Details
  7.5.2 Bharat Serum Major Business
  7.5.3 Bharat Serum Rabies Immune Globulin (Human) Product and Services
  7.5.4 Bharat Serum Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Bharat Serum Recent Developments/Updates
  7.5.6 Bharat Serum Competitive Strengths & Weaknesses
7.6 Bio Products Laboratory
  7.6.1 Bio Products Laboratory Details
  7.6.2 Bio Products Laboratory Major Business
  7.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
  7.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Bio Products Laboratory Recent Developments/Updates
  7.6.6 Bio Products Laboratory Competitive Strengths & Weaknesses
7.7 Shanghai RAAS
  7.7.1 Shanghai RAAS Details
  7.7.2 Shanghai RAAS Major Business
  7.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
  7.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Shanghai RAAS Recent Developments/Updates
  7.7.6 Shanghai RAAS Competitive Strengths & Weaknesses
7.8 Weiguang Bio
  7.8.1 Weiguang Bio Details
  7.8.2 Weiguang Bio Major Business
  7.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product and Services
  7.8.4 Weiguang Bio Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Weiguang Bio Recent Developments/Updates
  7.8.6 Weiguang Bio Competitive Strengths & Weaknesses
7.9 Shuanglin Bio
  7.9.1 Shuanglin Bio Details
  7.9.2 Shuanglin Bio Major Business
  7.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
  7.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Shuanglin Bio Recent Developments/Updates
  7.9.6 Shuanglin Bio Competitive Strengths & Weaknesses
7.10 CBPO
  7.10.1 CBPO Details
  7.10.2 CBPO Major Business
  7.10.3 CBPO Rabies Immune Globulin (Human) Product and Services
  7.10.4 CBPO Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 CBPO Recent Developments/Updates
  7.10.6 CBPO Competitive Strengths & Weaknesses
7.11 CNBG
  7.11.1 CNBG Details
  7.11.2 CNBG Major Business
  7.11.3 CNBG Rabies Immune Globulin (Human) Product and Services
  7.11.4 CNBG Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 CNBG Recent Developments/Updates
  7.11.6 CNBG Competitive Strengths & Weaknesses
7.12 Sichuan Yuanda Shuyang
  7.12.1 Sichuan Yuanda Shuyang Details
  7.12.2 Sichuan Yuanda Shuyang Major Business
  7.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
  7.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Sichuan Yuanda Shuyang Recent Developments/Updates
  7.12.6 Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
7.13 Kedrion Biopharma
  7.13.1 Kedrion Biopharma Details
  7.13.2 Kedrion Biopharma Major Business
  7.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
  7.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.13.5 Kedrion Biopharma Recent Developments/Updates
  7.13.6 Kedrion Biopharma Competitive Strengths & Weaknesses
7.14 Congruent Pharmachem
  7.14.1 Congruent Pharmachem Details
  7.14.2 Congruent Pharmachem Major Business
  7.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
  7.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.14.5 Congruent Pharmachem Recent Developments/Updates
  7.14.6 Congruent Pharmachem Competitive Strengths & Weaknesses
7.15 hualanbio
  7.15.1 hualanbio Details
  7.15.2 hualanbio Major Business
  7.15.3 hualanbio Rabies Immune Globulin (Human) Product and Services
  7.15.4 hualanbio Rabies Immune Globulin (Human) Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.15.5 hualanbio Recent Developments/Updates
  7.15.6 hualanbio Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Rabies Immune Globulin (Human) Industry Chain
8.2 Rabies Immune Globulin (Human) Upstream Analysis
  8.2.1 Rabies Immune Globulin (Human) Core Raw Materials
  8.2.2 Main Manufacturers of Rabies Immune Globulin (Human) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Rabies Immune Globulin (Human) Production Mode
8.6 Rabies Immune Globulin (Human) Procurement Model
8.7 Rabies Immune Globulin (Human) Industry Sales Model and Sales Channels
  8.7.1 Rabies Immune Globulin (Human) Sales Model
  8.7.2 Rabies Immune Globulin (Human) Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Rabies Immune Globulin (Human) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Rabies Immune Globulin (Human) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Rabies Immune Globulin (Human) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Rabies Immune Globulin (Human) Production Value Market Share by Region (2018-2023)
Table 5. World Rabies Immune Globulin (Human) Production Value Market Share by Region (2024-2029)
Table 6. World Rabies Immune Globulin (Human) Production by Region (2018-2023) & (K Units)
Table 7. World Rabies Immune Globulin (Human) Production by Region (2024-2029) & (K Units)
Table 8. World Rabies Immune Globulin (Human) Production Market Share by Region (2018-2023)
Table 9. World Rabies Immune Globulin (Human) Production Market Share by Region (2024-2029)
Table 10. World Rabies Immune Globulin (Human) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Rabies Immune Globulin (Human) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Rabies Immune Globulin (Human) Major Market Trends
Table 13. World Rabies Immune Globulin (Human) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Rabies Immune Globulin (Human) Consumption by Region (2018-2023) & (K Units)
Table 15. World Rabies Immune Globulin (Human) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Rabies Immune Globulin (Human) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Rabies Immune Globulin (Human) Producers in 2022
Table 18. World Rabies Immune Globulin (Human) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Rabies Immune Globulin (Human) Producers in 2022
Table 20. World Rabies Immune Globulin (Human) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Rabies Immune Globulin (Human) Company Evaluation Quadrant
Table 22. World Rabies Immune Globulin (Human) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Rabies Immune Globulin (Human) Production Site of Key Manufacturer
Table 24. Rabies Immune Globulin (Human) Market: Company Product Type Footprint
Table 25. Rabies Immune Globulin (Human) Market: Company Product Application Footprint
Table 26. Rabies Immune Globulin (Human) Competitive Factors
Table 27. Rabies Immune Globulin (Human) New Entrant and Capacity Expansion Plans
Table 28. Rabies Immune Globulin (Human) Mergers & Acquisitions Activity
Table 29. United States VS China Rabies Immune Globulin (Human) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Rabies Immune Globulin (Human) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Rabies Immune Globulin (Human) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Rabies Immune Globulin (Human) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Rabies Immune Globulin (Human) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Rabies Immune Globulin (Human) Production Market Share (2018-2023)
Table 37. China Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Rabies Immune Globulin (Human) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Rabies Immune Globulin (Human) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Rabies Immune Globulin (Human) Production Market Share (2018-2023)
Table 42. Rest of World Based Rabies Immune Globulin (Human) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production Market Share (2018-2023)
Table 47. World Rabies Immune Globulin (Human) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Rabies Immune Globulin (Human) Production by Type (2018-2023) & (K Units)
Table 49. World Rabies Immune Globulin (Human) Production by Type (2024-2029) & (K Units)
Table 50. World Rabies Immune Globulin (Human) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Rabies Immune Globulin (Human) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Rabies Immune Globulin (Human) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Rabies Immune Globulin (Human) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Rabies Immune Globulin (Human) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Rabies Immune Globulin (Human) Production by Application (2018-2023) & (K Units)
Table 56. World Rabies Immune Globulin (Human) Production by Application (2024-2029) & (K Units)
Table 57. World Rabies Immune Globulin (Human) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Rabies Immune Globulin (Human) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Rabies Immune Globulin (Human) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Rabies Immune Globulin (Human) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 62. CSL Behring Major Business
Table 63. CSL Behring Rabies Immune Globulin (Human) Product and Services
Table 64. CSL Behring Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CSL Behring Recent Developments/Updates
Table 66. CSL Behring Competitive Strengths & Weaknesses
Table 67. Grifols Basic Information, Manufacturing Base and Competitors
Table 68. Grifols Major Business
Table 69. Grifols Rabies Immune Globulin (Human) Product and Services
Table 70. Grifols Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Grifols Recent Developments/Updates
Table 72. Grifols Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Rabies Immune Globulin (Human) Product and Services
Table 76. Sanofi Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Kamada Basic Information, Manufacturing Base and Competitors
Table 80. Kamada Major Business
Table 81. Kamada Rabies Immune Globulin (Human) Product and Services
Table 82. Kamada Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Kamada Recent Developments/Updates
Table 84. Kamada Competitive Strengths & Weaknesses
Table 85. Bharat Serum Basic Information, Manufacturing Base and Competitors
Table 86. Bharat Serum Major Business
Table 87. Bharat Serum Rabies Immune Globulin (Human) Product and Services
Table 88. Bharat Serum Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Bharat Serum Recent Developments/Updates
Table 90. Bharat Serum Competitive Strengths & Weaknesses
Table 91. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 92. Bio Products Laboratory Major Business
Table 93. Bio Products Laboratory Rabies Immune Globulin (Human) Product and Services
Table 94. Bio Products Laboratory Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bio Products Laboratory Recent Developments/Updates
Table 96. Bio Products Laboratory Competitive Strengths & Weaknesses
Table 97. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 98. Shanghai RAAS Major Business
Table 99. Shanghai RAAS Rabies Immune Globulin (Human) Product and Services
Table 100. Shanghai RAAS Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Shanghai RAAS Recent Developments/Updates
Table 102. Shanghai RAAS Competitive Strengths & Weaknesses
Table 103. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 104. Weiguang Bio Major Business
Table 105. Weiguang Bio Rabies Immune Globulin (Human) Product and Services
Table 106. Weiguang Bio Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Weiguang Bio Recent Developments/Updates
Table 108. Weiguang Bio Competitive Strengths & Weaknesses
Table 109. Shuanglin Bio Basic Information, Manufacturing Base and Competitors
Table 110. Shuanglin Bio Major Business
Table 111. Shuanglin Bio Rabies Immune Globulin (Human) Product and Services
Table 112. Shuanglin Bio Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shuanglin Bio Recent Developments/Updates
Table 114. Shuanglin Bio Competitive Strengths & Weaknesses
Table 115. CBPO Basic Information, Manufacturing Base and Competitors
Table 116. CBPO Major Business
Table 117. CBPO Rabies Immune Globulin (Human) Product and Services
Table 118. CBPO Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CBPO Recent Developments/Updates
Table 120. CBPO Competitive Strengths & Weaknesses
Table 121. CNBG Basic Information, Manufacturing Base and Competitors
Table 122. CNBG Major Business
Table 123. CNBG Rabies Immune Globulin (Human) Product and Services
Table 124. CNBG Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CNBG Recent Developments/Updates
Table 126. CNBG Competitive Strengths & Weaknesses
Table 127. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 128. Sichuan Yuanda Shuyang Major Business
Table 129. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product and Services
Table 130. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 132. Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
Table 133. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 134. Kedrion Biopharma Major Business
Table 135. Kedrion Biopharma Rabies Immune Globulin (Human) Product and Services
Table 136. Kedrion Biopharma Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Kedrion Biopharma Recent Developments/Updates
Table 138. Kedrion Biopharma Competitive Strengths & Weaknesses
Table 139. Congruent Pharmachem Basic Information, Manufacturing Base and Competitors
Table 140. Congruent Pharmachem Major Business
Table 141. Congruent Pharmachem Rabies Immune Globulin (Human) Product and Services
Table 142. Congruent Pharmachem Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Congruent Pharmachem Recent Developments/Updates
Table 144. hualanbio Basic Information, Manufacturing Base and Competitors
Table 145. hualanbio Major Business
Table 146. hualanbio Rabies Immune Globulin (Human) Product and Services
Table 147. hualanbio Rabies Immune Globulin (Human) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Rabies Immune Globulin (Human) Upstream (Raw Materials)
Table 149. Rabies Immune Globulin (Human) Typical Customers
Table 150. Rabies Immune Globulin (Human) Typical Distributors

LIST OF FIGURES

Figure 1. Rabies Immune Globulin (Human) Picture
Figure 2. World Rabies Immune Globulin (Human) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rabies Immune Globulin (Human) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Rabies Immune Globulin (Human) Production (2018-2029) & (K Units)
Figure 5. World Rabies Immune Globulin (Human) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Rabies Immune Globulin (Human) Production Value Market Share by Region (2018-2029)
Figure 7. World Rabies Immune Globulin (Human) Production Market Share by Region (2018-2029)
Figure 8. North America Rabies Immune Globulin (Human) Production (2018-2029) & (K Units)
Figure 9. Europe Rabies Immune Globulin (Human) Production (2018-2029) & (K Units)
Figure 10. China Rabies Immune Globulin (Human) Production (2018-2029) & (K Units)
Figure 11. Japan Rabies Immune Globulin (Human) Production (2018-2029) & (K Units)
Figure 12. Rabies Immune Globulin (Human) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 15. World Rabies Immune Globulin (Human) Consumption Market Share by Region (2018-2029)
Figure 16. United States Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 17. China Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 18. Europe Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 19. Japan Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 22. India Rabies Immune Globulin (Human) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Rabies Immune Globulin (Human) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Rabies Immune Globulin (Human) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Rabies Immune Globulin (Human) Markets in 2022
Figure 26. United States VS China: Rabies Immune Globulin (Human) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Rabies Immune Globulin (Human) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rabies Immune Globulin (Human) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Rabies Immune Globulin (Human) Production Market Share 2022
Figure 30. China Based Manufacturers Rabies Immune Globulin (Human) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Rabies Immune Globulin (Human) Production Market Share 2022
Figure 32. World Rabies Immune Globulin (Human) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Rabies Immune Globulin (Human) Production Value Market Share by Type in 2022
Figure 34. HyperRAB S/D
Figure 35. KEDRAB
Figure 36. World Rabies Immune Globulin (Human) Production Market Share by Type (2018-2029)
Figure 37. World Rabies Immune Globulin (Human) Production Value Market Share by Type (2018-2029)
Figure 38. World Rabies Immune Globulin (Human) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Rabies Immune Globulin (Human) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Rabies Immune Globulin (Human) Production Value Market Share by Application in 2022
Figure 41. Clinic
Figure 42. Hospital
Figure 43. World Rabies Immune Globulin (Human) Production Market Share by Application (2018-2029)
Figure 44. World Rabies Immune Globulin (Human) Production Value Market Share by Application (2018-2029)
Figure 45. World Rabies Immune Globulin (Human) Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Rabies Immune Globulin (Human) Industry Chain
Figure 47. Rabies Immune Globulin (Human) Procurement Model
Figure 48. Rabies Immune Globulin (Human) Sales Model
Figure 49. Rabies Immune Globulin (Human) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source


More Publications